Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Rhea-AI Summary

Waters (NYSE: WAT) launched the Xevo TQ Absolute XR IVD Mass Spectrometer, a new component of its MassTrak LC-MS/MS IVD System portfolio, at the ADLM 2026 Annual Meeting. The IVD-compliant system targets routine clinical testing across women's health, hormone-related cancer assessment, and toxicology.

According to Waters, the Xevo TQ Absolute XR IVD System delivers up to 5x greater sensitivity than in-class instruments, enabling lower limits of detection from smaller sample volumes for complex biological matrices. The system features the new StepWave XR Ion Guide, which is reported to provide up to a six-fold increase in robustness versus the Xevo TQ Absolute IVD System by maintaining ion ratio consistency for longer when analyzing challenging clinical samples. The complete MassTrak LC-MS/MS IVD configuration pairs the Xevo TQ Absolute XR with the ACQUITY UPLC I-Class PLUS System to support fast, accurate analysis and a user-friendly design aimed at maximizing laboratory uptime. The system is available to order immediately.

Market Context

WAT's June 24 partnership event was followed by a 3.35% gain, while its June 8 product launch was fo...

Analysis

WAT's June 24 partnership event was followed by a 3.35% gain, while its June 8 product launch was followed by a 0.55% decline. That mixed product-news record adds context; the active S-3ASR shelf and low short positioning are additional factors to monitor.

Key Figures

Sensitivity improvement: 5x greater sensitivity Robustness improvement: Up to six-fold increase Ion ratio consistency: Up to six times longer +2 more

5 metrics

Sensitivity improvement 5x greater sensitivity Compared with other instruments in the same class

Robustness improvement Up to six-fold increase StepWave XR Ion Guide versus Xevo TQ Absolute MS

Ion ratio consistency Up to six times longer Compared with the Xevo TQ Absolute IVD System

Samples analyzed More than 12,000 samples Pesticides in a fish-feed matrix experiment

Launch date July 27, 2026 Xevo TQ Absolute XR IVD Mass Spectrometer announcement

Historical Context

5 past events · Latest: Jul 02 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 02	Earnings call scheduling	Neutral	+0.3%	Waters scheduled its second-quarter 2026 earnings conference call for August 4.
Jun 24	Strategic partnership	Positive	+3.4%	Waters partnered with IMU Biosciences on an AI-powered immune mapping platform.
Jun 09	Product launch	Positive	+2.1%	Waters launched a coin-cell calorimeter for integrated battery safety analysis.
Jun 08	Product launch	Positive	-0.6%	Waters introduced reversed-phase columns for faster GLP-1 and LNP characterization.
Jun 03	FDA clearance	Positive	+2.1%	Waters announced FDA 510(k) clearance for the BD BACTEC FXI system.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Most recent positive Waters announcements aligned with positive 24-hour reactions, while the June 8 product launch diverged with a negative reaction.

Key Terms

ivd, tandem quadrupole, lc-ms/ms, limits of detection

4 terms

ivd regulatory

"clinical applications across women's health, cancer assessment, and toxicology"

IVD stands for in vitro diagnostic — tests, instruments and kits that analyze samples taken from the body (blood, saliva, tissue) outside the body, such as lab assays or home pregnancy tests. Investors watch IVDs because they drive recurring sales, depend on regulatory approval and insurance coverage to reach markets, and differences in accuracy, cost or availability can quickly affect a maker’s revenue and legal risk.

tandem quadrupole technical

"industry-leading tandem quadrupole MS sensitivity"

A tandem quadrupole is a type of mass spectrometer made of two linked quadrupole stages separated by a collision cell, used to select, fragment and analyze molecules by mass. Think of it as a two-step filter and scanner that first picks a target, breaks it into pieces, then checks those pieces to confirm identity and amount; it matters to investors because it underpins lab tests in pharmaceuticals, diagnostics, environmental monitoring and quality control, driving sales of instruments and analytical services.

lc-ms/ms technical

"expanding its MassTrak IVD System portfolio of LC-MS/MS Systems"

LC‑MS/MS is a laboratory technique that first separates a mixture of chemicals in a liquid, then identifies and measures each component with very high sensitivity—think of sorting mixed mail and then scanning barcodes to know exactly what’s inside. It matters to investors because it produces precise, reliable data used in drug development, safety testing, diagnostics and product quality control, and those results influence regulatory approvals, market access and commercial claims that can affect a company’s value.

limits of detection technical

"the system enables lower limits of detection and reliable quantification"

The limits of detection are the smallest amount or concentration of a substance that a test, instrument, or assay can reliably distinguish from no signal or background noise. It matters to investors because a lower (better) limit of detection affects a product’s technical credibility, regulatory approval, and market competitiveness—similar to how a more sensitive smoke alarm can spot a faint fire earlier than a less sensitive one.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology.
• Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volumes, introducing a step-change in analytical performance for complex biological matrices.
• Up to six-fold increase in robustness with StepWave™ XR Ion Guide vs. Xevo TQ Absolute MS, advancing laboratory productivity and performance consistency.

MILFORD, Mass., July 27, 2026 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting — Waters Corporation (NYSE: WAT) today announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding its MassTrak™ IVD System portfolio of LC-MS/MS Systems with a solution that combines class-leading sensitivity and enhanced robustness for clinical applications. The new system builds on the industry-renowned step-change performance of the Xevo TQ Absolute IVD Mass Spectrometer, which established the benchmark for sensitivity among IVD-compliant tandem quadrupole mass spectrometers.¹

Developed for routine laboratory testing requiring IVD-compliant systems, the Xevo TQ Absolute XR IVD System delivers exceptional trace-level analytical performance in complex biological matrices. With up to five times greater sensitivity than other instruments in its class,¹ the system enables lower limits of detection and reliable quantification of challenging analytes from smaller sample volumes. This enhanced sensitivity is critical for applications requiring accurate measurement at very low concentrations, such as low-level estradiol testing for women's health and hormone-related cancer assessment,² and hair toxicology³ for detecting drugs of abuse and documenting long-term exposure.

"Waters' IVD Systems provide clinical diagnostic laboratories with highly precise and flexible solutions that help clinicians make informed decisions when every test matters," said Jianqing Bennett, Senior Vice President, Waters Advanced Diagnostics, Waters Corporation. "With the introduction of the Xevo TQ Absolute XR IVD System, Waters is delivering a new standard of sensitivity and robustness that can significantly reduce downtime and improve laboratory productivity. Waters is uniquely positioned to help clinical laboratories develop reliable methods for complex analytes and expand their testing capabilities to meet growing demand across women's health, cancer assessment, and toxicology applications."

Featuring the new StepWave™ XR Ion Guide, the Xevo TQ Absolute XR IVD System delivers improved robustness, enabling ion ratio consistency for up to six times longer compared with the Xevo TQ Absolute IVD System.⁴ This advancement gives laboratories greater confidence in consistent performance when analyzing complex clinical samples containing phospholipids, salts, and other matrix components.

"Having the Xevo TQ Absolute XR IVD Systems in our laboratory is a major advancement for the company," said James Nutt, Head of Laboratory Operations, Cansford Laboratories. "The systems strengthen our analytical reliability, have the potential to greatly expand our substance testing capabilities, and improve operational efficiency. They deliver better signal stability and improved sensitivity, which is especially important when working close to decision cut-offs in complex matrices such as human hair. This gives us greater confidence in our results and provides additional assurance when measuring analytes at very low concentrations."

This new MassTrak LC-MS/MS IVD System includes the ACQUITY™ UPLC I-Class PLUS System with the Xevo TQ Absolute XR IVD Mass Spectrometer. The ACQUITY UPLC I-Class PLUS System is designed to deliver fast, accurate sample analysis that enhances mass spectrometer performance and simplifies the characterization of complex samples. Together, the integrated system delivers industry-leading sensitivity, enhanced robustness for complex sample matrices, and a user-friendly design that helps maximize laboratory uptime.

The MassTrak LC-MS/MS IVD System with the Xevo TQ Absolute XR Mass Spectrometer is available to order now.

Additional Resources:

• Product Page
• Application Note: Utilizing the New Xevo TQ Absolute XR Mass Spectrometer for the LC-MS/MS Analysis of Serum Estrogens for Clinical Research
• Application Note: Extraction and Analysis of a Definitive Drug Panel in Hair Samples by UHPLC-MS/MS for Forensic Toxicology

Xevo, StepWave, MassTrak, ACQUITY, and Waters are trademarks of Waters Corporation or its affiliates. All other marks are the property of their respective owners.

About Waters Corporation:

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about. 

References:

1. Waters comparison of Xevo TQ Absolute XR IVD vs. existing Waters Xevo TQ-XS IVD and the SCIEX 6500 IVD, which are the next two most sensitive IVD-compliant tandem quadrupole products currently available for commercial sale. 

2. Application Note: "Utilizing the New Xevo TQ Absolute XR Mass Spectrometer for the LC-MS/MS Analysis of Serum Estrogens for Clinical Research"; published May 20, 2026.

3. Application Note: "Extraction and Analysis of a Definitive Drug Panel in Hair Samples by UHPLC-MS/MS for Forensic Toxicology"; published June 10, 2025.

4. Application Note on Product Webpage. In a well-controlled experiment, performance was maintained for up to six times the duration on the Xevo TQ Absolute XR MS compared to the Xevo TQ Absolute MS; more than 12,000 samples of pesticides in fish feed matrix were analyzed.

Contact:
Molly Gluck
Head of External Communications
Waters Corporation
508.498.9732
molly_gluck@waters.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-launches-industrys-most-sensitive-and-robust-clinical-ivd-system-with-xevo-tq-absolute-xr-ivd-mass-spectrometer-302835195.html

SOURCE Waters Corporation

FAQ

What is the Xevo TQ Absolute XR IVD System launched by Waters (NYSE: WAT) in July 2026?

The Xevo TQ Absolute XR IVD System is a clinical LC‑MS/MS platform designed for high-sensitivity routine diagnostics. According to Waters, it extends the MassTrak IVD portfolio with an IVD-compliant tandem quadrupole mass spectrometer focused on women’s health, cancer assessment, and toxicology applications.

How much more sensitive is the Waters Xevo TQ Absolute XR IVD Mass Spectrometer (WAT) compared with in-class instruments?

According to Waters, the Xevo TQ Absolute XR IVD System delivers up to five times greater sensitivity than other instruments in its class. This higher sensitivity supports lower detection limits and reliable quantification of challenging analytes from smaller sample volumes in complex biological matrices.

What robustness improvement does the StepWave XR Ion Guide bring to the Xevo TQ Absolute XR IVD System from Waters (WAT)?

Waters reports that the StepWave XR Ion Guide enables up to a six-fold increase in robustness versus the Xevo TQ Absolute IVD System. In controlled experiments, ion ratio consistency was maintained for much longer when analyzing complex samples containing phospholipids, salts, and other matrix components.

Which clinical applications does the Waters Xevo TQ Absolute XR IVD System (WAT) target?

The Xevo TQ Absolute XR IVD System is aimed at women’s health, cancer assessment, and toxicology testing. According to Waters, it supports low-level estradiol measurement, hormone-related cancer assessment, and hair toxicology for drugs of abuse and long-term exposure documentation.

What components are included in the MassTrak LC-MS/MS IVD System with Xevo TQ Absolute XR from Waters (WAT)?

The MassTrak LC-MS/MS IVD System combines the Xevo TQ Absolute XR IVD Mass Spectrometer with the ACQUITY UPLC I-Class PLUS System. According to Waters, this integrated setup provides fast, accurate sample analysis, high sensitivity, and a user-friendly design to maximize laboratory uptime.

When is the Waters Xevo TQ Absolute XR IVD Mass Spectrometer (NYSE: WAT) available for purchase?

According to Waters, the MassTrak LC-MS/MS IVD System with the Xevo TQ Absolute XR IVD Mass Spectrometer is available to order now. Customers can access product details and supporting application notes through Waters’ online product page and related technical resources.

How does the Waters Xevo TQ Absolute XR IVD System support low-level estradiol and hormone testing?

The Xevo TQ Absolute XR IVD System provides high sensitivity suitable for accurate measurement at very low analyte concentrations. According to Waters, it supports LC‑MS/MS analysis of serum estrogens, including low-level estradiol, for women’s health and hormone-related cancer assessment in clinical research settings.